Atypical inflammatory demyelinating syndromes of the CNS

TA Hardy, SW Reddel, MH Barnett, J Palace… - The Lancet …, 2016 - thelancet.com
Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple
sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for …

Tumefactive demyelination: an approach to diagnosis and management

TA Hardy, J Chataway - Journal of Neurology, Neurosurgery & …, 2013 - jnnp.bmj.com
Tumefactive lesions are an uncommon manifestation of demyelinating disease and can
pose a diagnostic challenge in patients without a pre-existing diagnosis of multiple sclerosis …

Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients

M Fereidan‐Esfahani, PA Decker… - Annals of Clinical …, 2023 - Wiley Online Library
Objective To describe demographic, clinical, and radiographic features of tumefactive
demyelination (TD) and identify factors associated with severe attacks and poor outcomes …

Acute disseminated encephalomyelitis

G Alper - Journal of child neurology, 2012 - journals.sagepub.com
Acute disseminated encephalomyelitis is an immune-mediated inflammatory and
demyelinating disorder of the central nervous system, commonly preceded by an infection. It …

Baló's concentric sclerosis

TA Hardy, DH Miller - The Lancet Neurology, 2014 - thelancet.com
Baló's concentric sclerosis is often regarded as a rare variant of multiple sclerosis. Patients
with this disorder present with acute or subacute neurological deterioration, with MRI …

Tumefactive demyelinating lesions: a comprehensive review

H Algahtani, B Shirah, A Alassiri - Multiple sclerosis and related disorders, 2017 - Elsevier
Tumefactive multiple sclerosis or tumefactive demyelinating lesion (TDL) is one of the rare
variants of multiple sclerosis (MS) posing a diagnostic challenge and a therapeutic enigma …

A review of clinical and imaging findings in tumefactive demyelination

M Nakayama, S Naganawa, M Ouyang… - American Journal of …, 2021 - Am Roentgen Ray Soc
OBJECTIVE. Tumefactive demyelination mimics primary brain neoplasms on imaging, often
necessitating brain biopsy. This article reviews the literature for the clinical and radiologic …

Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome

TA Hardy - Current opinion in neurology, 2019 - journals.lww.com
Not all patients with pseudotumoral lesions require a brain biopsy but close follow-up of
biopsied and nonbiopsied lesions is indicated once a diagnosis is established. Testing for …

MRI findings in tumefactive demyelinating lesions: a systematic review and meta-analysis

CH Suh, HS Kim, SC Jung… - American Journal of …, 2018 - Am Soc Neuroradiology
BACKGROUND: Accurate diagnosis of tumefactive demyelinating lesions is clinically
important to avoid unnecessary invasive biopsy or inappropriate treatment. PURPOSE: We …

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

M Wallner-Blazek, A Rovira, M Fillipp, MA Rocca… - Journal of …, 2013 - Springer
Atypical lesions of a presumably idiopathic inflammatory demyelinating origin present quite
variably and may pose diagnostic problems. The subsequent clinical course is also …